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Abstract
Parkinson’s disease is associated with intracellular α-synuclein accumulation and ventral midbrain dopaminergic neuronal death
in the Substantia Nigra of brain patients. The Rho GTPase pathway, mainly linking surface receptors to the organization of the
actin and microtubule cytoskeletons, has been suggested to participate to Parkinson’s disease pathogenesis. Nevertheless, its
exact contribution remains obscure. To unveil the participation of the Rho GTPase family to the molecular pathogenesis of
Parkinson’s disease, we first used C elegans to demonstrate the role of the small GTPase RAC1 (ced-10 in the worm) in
maintaining dopaminergic function and survival in the presence of alpha-synuclein. In addition, ced-10 mutant worms deter-
mined an increase of alpha-synuclein inclusions in comparison to control worms as well as an increase in autophagic vesicles.We
then used a human neuroblastoma cells (M17) stably over-expressing alpha-synuclein and found that RAC1 function decreased
the amount of amyloidogenic alpha-synuclein. Further, by using dopaminergic neurons derived from patients of familial LRRK2-
Parkinson’s disease we report that human RAC1 activity is essential in the regulation of dopaminergic cell death, alpha-synuclein
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accumulation, participates in neurite arborization and modulates autophagy. Thus, we determined for the first time that RAC1/
ced-10 participates in Parkinson’s disease associated pathogenesis and established RAC1/ced-10 as a new candidate for further
investigation of Parkinson’s disease associated mechanisms, mainly focused on dopaminergic function and survival against α-
synuclein-induced toxicity.
Keywords Parkinson’s disease .Dopaminergic neurons .Alpha-synuclein accumulation .Autophagy impairment .RAC1/ced-10
Introduction
Parkinson’s disease (PD) is the second most frequent neurode-
generative disorder in the elderly. While most of cases are spo-
radic, monogenic PD caused by pathogenic point mutations in
PD-associated genes occurs in less than 10% of cases (reviewed
in [1]). The common neuropathological hallmarks of PD in-
clude a selective loss of the dopaminergic neurons (DAn) in
the Substantia Nigra pars compacta and aggregation of the
protein alpha-synuclein (α-SYN) in the surviving DAn and in
the so called Lewy bodies (LB) and Lewy neurites (LN) which
are found in the few survivingDAn (reviewed in [2]).α-SYN is
intrinsically misfolded in pathological conditions such as PD
[3] and formsmultiple conformations, including amyloidogenic
oligomers [4, 5] implicated in α-SYN toxicity [6].
There exist evidences of an essential role of actin cytoskel-
eton disruptions in both DAn cell death [7, 8] and α-SYN
accumulation [9]. In fact, the cytoskeleton is an important
target of α-SYN [10] and neuronal microtubule-kinesin func-
tion could be impaired by α-SYN oligomers [11]. Actin cyto-
skeletal organization is regulated by small GTPases of the Rho
family encompassing Rho, Cdc42 and Rac subfamily mem-
bers [7]. These proteins act as molecular switches as they
alternate between the active GTP-bound and the inactive
GDP-bound forms [8, 16]. GTP binding increases the activity,
and the hydrolysis of GTP to GDP renders the protein inac-
tive. More specifically, RAC1 activity is mainly associated
with cellular processes involving the regulation of actin poly-
merization such as cell migration, lamellipodia extension or
the phagocytosis of dead cells or engulfment [12]. In addition,
RAC1 participates in the extension and retraction of neurites
[13] and, together with other members of the Rho family,
govern changes in neuronal morphology and the dynamics
of neuronal processes (reviewed in [8]).
RAC1 function has been associated with two PD-related
genes. We have previously shown in C elegans that RAC1 is
ubiquitylated by PARKIN [14], mutated in the juvenile variant
of PD. Likewise, Leucine-rich repeat kinase 2 (LRRK2), in
which mutations cause the most common form of familial PD
[15], strongly and selectively binds to RAC1 [16].
Furthermore, neuronal apoptosis induced in DAn in vitro is
correlated with decreased RAC1 activity [17]. In contrast, in a
monkeymodel of PD, it was suggested that aberrant activation
of RAC1 in microglia may contribute to enhanced production
of ROS underlying the death of neighboring DAn [18].
Therefore understanding the cytoskeletal mechanisms associ-
ated with DA cell death and α-SYN degradation is important
to elucidate other causative agents of the PD pathophysiology.
Autophagic flux is profoundly disrupted in PD patients
(reviewed in [1] and α-SYN is normally degraded by autoph-
agy [19]. Indeed, autophagy has been associated with PD
pathogenesis through several genes, such as LRRK2 [20],
ATG9A [21] or ATG8/LC3 [22], and cellular processes such
as lysosomal disruption [23, 24]. In addition, autophagy-
related gene products are required for apoptotic clearance,
either in dying cells or through a role in engulfment, in where
RAC1 has a pivotal role [25–27].
In the present study we have systematically investigated
RAC1 function in three disease models of PD including the
following: (a) C elegans models of PD; (b) human-derived
neuroblastoma BE(2) (M17) cells stably over-expressing α-
SYN, wherein amyloidigenic accumulation of α-SYN is in-
duced by sodium butyrate; and (c) iPSC-derived DAn generat-
ed by cell reprogramming of somatic skin cells from patients
with monogenic LRRK2-associated PD [20]. Using these
models, we determine for the first time that RAC1/ced-10 par-
ticipates specifically in PD-associated pathogenesis and estab-
lish RAC1/ced-10 as a new candidate to be considered for the
investigation of PD-associated mechanisms, mainly focused on
DA function and survival against α-SYN-induced toxicity.
Results
RAC1/ced-10 Cell-Autonomous Depletion in DAn
Hampers Dopamine- Associated Behavior
in the Presence of α-SYN and Accelerates α-SYN
Induced DAn Death in C elegans
We first investigated the role of RAC1/ced-10 in DAn function,
by performing behavioral assays through analyzing the DA
behavior in ced-10(n3246) mutant animals. The mutation ced-
10(n3246) is a G-to-A transition resulting in a change of glycine
60 of CED-10 to arginine (G60R) which results in non-null
altered function [28, 29]. The severity of this allele is stronger
in contrast to other ced-10 alleles (11). To explore the role of
ced-10 in PD pathogenesis, all the experiments included in this
study involving the ced-10 gene were performed in a ced-
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10(n3246) mutant background. To simplify, ced-10(n3246) is
named ced-10 from here on.
The basal slowing response is a DA dependent behavior
widely used in C elegans for analyzing the functionality of
the DA system [30–32]. Briefly, worms decrease locomotion
speed when in physical contact with a food source whereas the
turn frequency increases when worms leave the food source
[31, 33]. The cat-2 gene encodes the enzyme tyrosine hydrox-
ylase required for the synthesis of dopamine. Accordingly, cat-
2(e1112)mutant worms have decreased levels of dopamine and
altered DA behavior [30, 33] and were used as positive control.
The locomotion speed of the nematodes, represented by the
body bends every 20 s, was measured in the absence/presence
of bacteria (+/−) (Fig. 1a). In a wild type background (wt back-
ground), both wild type and ced-10 animals decreased the lo-
comotion speed in the presence of food, thus showing unaltered
basal slowing response. In contrast, in cat-2(e1112)mutants the
locomotion speed was not significantly decreased by the pres-
ence of food (Fig. 1a wt background, and Table 1). Similarly to
the slow basal response, avoidance against ethanol is a sensory
behavior associated with DA signaling [34]. A slight decrease
was observed in the ethanol avoidance test performed in ced-10
mutant animals in a wt background (Fig. 1b wt background and
Table 2).
The absence of significant dopaminergic behavioral alter-
ations observed in ced-10 mutants might be the consequence
of compensating mechanisms existing in the worm that mask
the effect of ced-10 function specifically in DAn. To discard
any effect of ced-10 function onto DA responses, ced-10 was
depleted conditionally in DAn by RNAi, in a C. elegans PD
model in which DAn undergo age-dependent neurodegenera-
tion following humanα-SYN overexpression [35]. In this mod-
el, animals express both α-SYN and GFP in DAn. Importantly,
this is a neuronal-sensitive RNAi strain whereby the impact of
RNAi knockdown targeting gene candidates can be selectively
examined exclusively in the DAn [36] To simplify, this strain is
called Pdat-1::α-SYN + Pdat-1::GFP herein. Animals exposed
to ced-10 RNAi showed a mild but significant altered slow
Fig. 1 DAn function is hampered by specific depletion of RAC1/ced-10
in DAn expressing α-SYN in C elegans, aModulation of the locomotor
rate. Well-fed animals were transferred to assay plates without or with a
bacterial lawn (−/+) and 5 min later, the locomotor rate (body bends every
20 s) of each animal was analyzed. Statistical significance shows
comparison of the bending within same genotype animals (wild type,
ced-10(n3246) and cat-2 (e1112)) without (−) or with (+) bacteria.
RNAi experiments indicate Pdat-1::α-SYN +Pdat-1:: GFP worms fed
with EV (empty vector) or with the indicated RNAi clones. b Test of
ethanol avoidance. The percentage (%) of ethanol avoidance was
analyzed at the indicated genotypes. Statistical analysis shows
comparisons between wild type animals and mutants, and Pdat-1::α-
SYN +Pdat-1:: GFP worms fed either with EV (empty vector) or with
the indicated RNAi clones. cat-2 (e1112)mutant worms were included as
positive controls for both assays. Slow response assay and ethanol
avoidance behaviors were hampered in ced-10 depleted animals and not
in ced-10(n3246)mutants. Data are mean ± SEM. * P < 0.05, **P < 0.01,
***P < 0.001, ns non-significant. Statistics: one-way ANOVA, Tukey
post hoc test for multiple comparisons. Between 20 and 30 worms were
used in three independent replicates
Table 1 Slow dose response






Wild type 20.00 ± 0.423 9.55 ± 0.328 P < 0.001
ced-10(n3246) 19.05 ± 0.211 13.00 ± 0.145 P < 0.001
cat-2 (e1112) 21.00 ± 0.191 20.00 ± 0.162 ns
UA196 on EV 18.40 ± 0.255 9.20 ± 0.257 P < 0.001
UA196 on ced-10 RNAi 16.00 ± 0.254 13.15 ± 0.392 P < 0.001
UA196 on cat-2 RNAi 17.25 ± 0.502 16.40 ± 0.689 ns
Mean and SEM reported, n = 20. One-way ANOVA
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response assay (Fig. 1a and Table 1). In addition, selective
depletion of ced-10 in DAn resulted in similar avoidance
against ethanol as cat-2 depleted animals in the ethanol avoid-
ance test (Fig. 1b and Table 2). Therefore, in the presence of α-
SYN, ced-10 function is specifically necessary in C elegans
DAn to execute a correct DA behavioral response.
This negative impact of ced-10 depletion on DAn behavior
brought us to explore the relevance of ced-10 deficiency in
DAn cell death in the above mentioned strain Pdat-1::α-SYN
+ Pdat-1::GFP. There exist four pairs of DAn in C elegans
hermaphrodites, three of them (CEPD, CEPV and ADE) lo-
cated in the anterior part, and one pair, the PDE, located in the
posterior part of the nematode [37]. In this nematode, when
human α-SYN is expressed in DAn, the six DAn within the
anterior region of the worm display progressive degenerative
characteristics [38]. To draw parallels between human PD
evidenced in aged populations and this worm model, we
sought to determine the relevance of ced-10 depletion at 9 days
(L4 + 7) post hatching. Cell bodies and neuronal processes
were assessed to determine whether these structures were nor-
mal or displayed degenerative changes, and consequently con-
sidered wild type neurons (Fig. 2). After feeding worms with
EV RNAi, 24.93 ± 2.54% of animals showed the six anterior
wild type DAn. In contrast, ced-10 RNAi knockdown signif-
icantly enhanced DA neurodegeneration, 8.33 ± 1.67% of an-
imals showed the intact set of DAn (***P < 0.001)) in com-
parison with EV control (Fig. 2a, b). Animals expressing the
fusion protein, CFP::CED-10, under ced-10 promoter, rescued
α-SYN induced-neurodegeneration (***P < 0.001) (Fig. 2a,
b). We found that neurodegeneration was accelerated already
at day 3 and 5 (L4 + 1 and L4 + 3, respectively) post hatching
(Online Resource 1) thus corroborating the impact of ced-10
in α-SYN-induced DA cell death at younger ages.
CED-10 Expression Decreases α-SYN Inclusions
Formation in C elegans
The term phagocytosis refers also to the mechanism by which
certain cells engulf and digest other cells and also larger parti-
cles or even anomalous inclusions or aggregates [39, 40].
RAC1/ced-10 is the converging gene of the engulfment ma-
chinery mobilizing actin pseudopodia in phagocytic cells [12].
Therefore, we considered the possibility of ced-10 playing a
role in the clearance/phagocytosis of α-SYN inclusions. We
used a nematode model of PD, in which human α-SYN is
fused to the yellow fluorescent protein (YFP) under control
of the body wall muscle unc-54 promoter, transgene
pkIs2386 [Punc-54::α-SYN::YFP] [41]. With this approach
we examined changes in apparent aggregate density or aggre-
gate count of pathogenic α-SYN conjugated to fluorescent
YFP in muscle cells [42], without considering neuronal side
effects. Accordingly, ced-10 animals were crossed with
pkIs2386 worms and the number of α-SYN aggregates was
evaluated in aged worms at 7 days post hatching. This ced-10
mutation increased to 1.5 units the apparent density of α-SYN
inclusions in comparison to control worms (0.9 ± 0.06 vs. 1.49
± 0.06, respectively; ***P < 0.001) (Fig. 3a, b) thus suggesting
a deleterious effect of the ced-10mutation in the generation of
α-SYN aggregates. Importantly, the increase in α-SYN appar-
ent aggregates was abolished in transgenic ced-10 mutants
expressing the CFP::CED-10 fusion protein (array
baEx167[Pced-10::CFP::ced-10]) (0.42 ± 0.03 in worms ex-
pressing CED-10 wild type vs. 1.49 ± 0.06 in ced-10 mutant
worms respectively and Fig. 3a, b, ***P < 0.001), showing
that the lack of ced-10 is contributing to α-SYN accumulation.
The number of body thrashes or thrashing have been used
extensively to identify modifiers of protein aggregation [41,
43]. Thrashing in C elegans can be measured in liquid media
by counting the number of body bends per unit of time [44].
Using this method, we confirmed the observed damaged mo-
tility (Fig. 3c andOnline Resources 2–4) of the PD worms in
a ced-10 background. Whereas a decrease of 27% in the bend-
ing are observed in animals expressing YFP::α-SYN in com-
parison to the wild type N2 wild type strain (55.01 ± 7.5 vs.
75.96 ± 2.8 bends/min, respectively), the number of bends de-
creases almost 90% in animals harboring the ced-10mutation
in a YFP::SYN background in comparison with N2 wild type
animals (7.93 ± 4.4 vs. 75.96 ± 2.8 bends/min, respectively)
and 70% in comparison with worms expressing YFP::SYN,
without the ced-10mutation (7.93 ± 4.4 vs. 55.01 ± 7.5 bends/
min, respectively). Thus, increased α-SYN in muscle with its
concomitant locomotion decrease in ced-10 mutants, indicate
the involvement of RAC1/ced-10 in the process of α-SYN
accumulation in C. elegans.
α-SYN variants that form oligomers and protofibrils are
associated to the most severe DAn nigral loss in PD models
[1, 6]. To identify the biochemical nature of the apparent α-
SYN aggregates increased by this ced-10 mutation, worm
lysates from pkIs2386 worms without and with the ced-10
mutation at L4+ 5 days of development, were sequentially
extracted by detergent-containing buffers [45] and the amount
of α-SYN extracted in each fraction was assessed by immu-
noblotting (Fig. 3d). A faint band of 19 kDa was detected in
Table 2 Ethanol avoidance quantifications
Genotype Avoidance (% of worms) N Significance
(P value)
Wild type 71.21 ± 2.120 155 –
ced-10(n3246) 57.80 ± 3.957 94 P < 0.05
cat-2 (e1112) 26.67 ± 3.335 80 P < 0.001
UA196 on EV 70.35 ± 1.213 122 –
UA196 on ced-10 RNAi 12.95 ± 1.328 95 P < 0.001
UA196 on cat-2 RNAi 10.902 ± 1.524 175 P < 0.001
Mean and SEM reported. One-way ANOVA
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the Tris-HCl fraction, most probably corresponding to the α-
SYN monomer staining. The number of oligomeric species is
increased in ced-10 mutant animals within all analyzed
fractions.
Autophagy Is Impaired in ced-10(n3246) Mutant
Animals
Autophagy is considered one of the main pathways in-
volved in α-SYN clearance [19, 46]. Given the role of
RAC1/ced-10 detected in α-SYN levels and in α-SYN-
induced DAn cell death, we further sought to determine
the participation of ced-10 in the modulation of autoph-
agy in C elegans. To this end, we first crossed ced-10
mutant animals with those carrying the array adIs2122
[Plgg-1::gfp::lgg-1]. The gene lgg-1 encodes a ubiquitin-
like protein belonging to the Atg8/LC3 protein family,
and the respective GFP::LGG-1 translational fusion thus
allows to monitor autophagosome formation via fluores-
cence microscopy [47]. To explore the role of ced-10 in
autophagy, we manually counted the number of
GFP::LGG-1 puncta present in the seam cells [48]. At
the L3 stage, the number of puncta present in the seam
cells were increased in animals harboring the ced-10
mutation, in comparison to animals without the muta-
tion, in where the GFP::LGG-1 pattern is mainly diffuse
(Fig. 4a, b). An increase in the number of GFP::LGG-1
puncta may result from either elevated or impaired au-
tophagic flux [48, 49]. Therefore, we investigated the
involvement of RAC1/ced-10 in autophagic pathways
Fig. 2 CED-10 protects DAn from α-SYN-induced DA cell death in C
elegans. Representative RNAi empty vector (EV) fed worms expressing
GFP andα-SYN specifically in DAn (Pdat-1::α-SYN + Pdat-1:: GFP) at
L4 + 7days (9 days post hatching) and fed with empty vector (EV) or ced-
10 RNAi clones. Filled white arrowhead labels healthy neurons whereas
degenerated or missing neurons are labeled with an open arrow. a ced-10
depletion reduces the amount of DAn per worm and the expression of the
CED-10::CFP transgene {baEx167 [Pced-10::CFP::ced-10]} delays the
DA cell death at the same age. Magnification bar is 30 μm. b Percentage
of Pdat-1:: α-SYN + Pdat-1:: GFP worms non-depleted and ced-10
depleted by RNAi, that had the full complement of six anterior DAn at
day 7 post L4. The transgenic derivative strain UA281 expressing
CFP::CED-10 (CED-10 wild type), carrying the array baEx167 [Pced-
10::CFP::ced-10] ameliorates the DA cell death. Data are mean ± SEM.
Statistics were obtained by comparing ced-10 RNAi depleted worms or
worms containing the CFP::CED-10 array with the corresponding EV fed
animals. Statistics: ***P < 0.001, one-way ANOVA, Tukey’s post hoc
test. Number of animals is 30–35 per condition, and the experiment was
repeated three times independently
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by analyzing the impact of the ced-10 mutation in the
autophagy-associated reporter strain bpIs51 [Psqst-1-
: : s q s t - 1 : : g f p + u n c - 7 6 (+ ) ] . T h e C . e l e g a n s
SeQueSTosome-related protein, SQST-1, exhibits se-
quence similarity to mammalian SQSTM1/p62 and is
degraded by autophagy [48, 50]. As such, autophagy
impairment is often associated with SQST-1::GFP accu-
mulation [48–50]. Similarly to the results obtained with
the GFP::LGG-1 reporter, ced-10 mutant animals
displayed increased SQST-1::GFP internal density (Fig.
4c–e). Whereas SQST-1::GFP staining was barely detect-
ed in wild type animals (Fig. 4c, d upper panels, and e),
ced-10 worms displayed SQST-1::GFP accumulation
(Fig. 4c, d bottom panels, and e). Cumulatively, these
results suggest a role of RAC1/ced-10 in the regulation
of autophagy.
Fig. 3 ced-10 decreases α-SYN inclusions in C elegans. a
Representative confocal pictures obtained from animals containing the
genomic array pkIs2386 [Punc-54::α-SYN::YFP] expressing α-SYN in
body wall muscle cells at L4 + 5 days of development (7 days post
hatching). Green staining in all figures represents α-SYN::YFP
inclusions in muscle cells. The vulva (V, thick arrow) was used as a
reference to analyze the same central section in all worms. A
representative area was highlighted and expanded in each panel, to
better visualize the α-SYN::YFP accumulation. a (first panel) α-SYN
inclusions were detected in a C. elegans model of α-SYN miss folding
in which α-SYN is expressed under the control of the unc-54 promoter. a
(second panel) α-SYN apparent aggregates are increased in ced-
10(n3246) mutant nematodes. a (third panel) CFP::CED-10 expression
(array baEx167 [Pced-10::CFP::CED-10]) decreased the number of α-
SYN inclusions in a ced-10(n3246) background. a (fourth panel) The
blue fluorescence marker (CFP) represented the endogenous expression
of CED-10 in a ced-10(n3246) background for rescuing α-SYN
accumulation. Magnification bar is 10 μm. b Quantification of the
number of α-SYN inclusions per area. Data are mean ± SEM. Between
30 and 35 animals were analyzed per genotype. Three different transgenic
lines expressing CFP::CED-10 were generated and analyzed
independently. Statistics: one-way ANOVA with a Tukey post hoc test.
***P < 0.005. c The movement of YFP::α-SYN animals is hampered by
the mutation ced-10n(3246). Thrashing behavior (bends/min) was video
recorded and the resulting images were analyzed by the ImageJ software.
Data are mean ± SEM. Between 20 and 30 animals were recorded per
experiment and the same experiment was repeated 3 independent times. d
Immunoblotting analysis of protein extracts from 5 days post L4 old
YFP::α-SYN synchronized animals, using anti-α- SYN antibody
without and with the ced-10(n3246) mutation (wild type and ced-10
respectively). The amount of α-SYN insoluble species was increased
by the ced-10(n3246) mutation.
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Human RAC1 Expression Reduces α-SYN
Accumulation and Amyloidogenic Aggregation
in a Neuroblastoma Cell Line
We further explored the effect of RAC1 on α-SYN accu-
mulation using a stable BE(2)-M17 neuroblastoma cell
line over-expressing wild type α-SYN. As previously re-
ported [51], differentiation with retinoic acid (RA) and
treatment with the histone deacetylases inhibitor sodium
butyrate (SB) increased α-SYN expression by twofold
and induced the accumulation of small α-SYN cytoplas-
mic aggregates (Online Resource 5a–b). Differentiated
cells treated with SB were transduced with a lentiviral
vector (LV) expressing either RAC1 wild type (WT)-
GFP (in which RAC1-GTP and RAC1-GDP coexist) or
RAC1 constitutively active (CA)-GFP (only expressing
RAC1-GTP) and analyzed 4 days post-transduction, using
the empty vector (Control-GFP) as a control. Infection
with both, RAC1 (WT) and RAC 1(CA) decreased α-
SYN expression level (Online Resource 5b) and
aggregation, as shown by Thioflavin S (ThyoS) dye
(Fig. 5), which specifically stains cross-beta sheet fibrils,
such those forming amyloid aggregates [52]. The area
covered by ThyoS -positive α-SYN aggregates per cell
was decreased by 90% in RAC1(WT) and RAC1(CA)
infected cultures (Fig. 5) thus suggesting a role of
RAC1 in either the formation or clearance of toxic α-
SYN species and corroborating the data obtained by west-
ern blot in the nematode.
High RAC1 Activity Reduces α-SYN Levels
and Increases Neurite Arborization in PD
Patient-Specific Midbrain iPSC-Derived DAn
Lastly, to connect the nematode data with the human PD,
we differentiated DAn upon cell reprogramming of skin
fibroblasts into induced pluripotent stem cells (iPSC)
from PD patients carrying the G2019S (G/S) mutation in
the LRRK2 gene. While preserving the patient genetic
background, this model exhibits some characteristic
Fig. 4 Autophagic markers accumulate in ced-10 mutant worms. a L4
worms expressing the reporter GFP::LGG-1 (adIs2122 [Plgg-
1::GFP::lgg-1; rol-6(su1006)] in hypodermal seam cells, without (left
panel, wild type) and with (right panel) the ced-10(n3246) mutation.
GFP::LGG-1 puncta are labeled with an filled arrow. Magnification bar
is 5 μm. b The bar graph indicates the number of GFP::LGG-1 foci per
cell at the indicated genotypes. These results are mean ± SEM of three
independent experiments performed in triplicate. Statistics is Student’s t
test. ***P ≤ 0.001. c, dWorms expressing the autophagy reporter SQST-
1::GFP (bpIs151[Psqst-1::sqst-1::GFP]) were crossed with ced-10(3246)
animals and the GFP fluorescence intensity (FI) was analyzed under a
fluorescence (c) or a confocal (d) microscope. d (upper panel) L4 animals
expressing the array SQST-1::GFP without induction of the GFP reporter
in normal conditions. d (bottom panel) The ced-10(n3246) mutation
increased GFP intensity and aggregation. Magnification bar is 20 μm. e
Normalized fluorescence intensity (FI) observed in SQST-1::GFP
animals without and with the ced-10(n3246) mutation. Thirty animals
were analyzed per genotype. Data are represented as the mean ± SEM
and were obtained by comparing wild type animals (without the ced-
10(n3246) mutation) with ced-10 mutated animals. Statistics,
***P < 0.001, Student’s t test
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features and cellular phenotypes of PD including reduced
axonal outgrowth, α-SYN accumulation, α-SYN-induced
DAn cell death, and impaired autophagy [20]. Therefore,
it represents a suitable tool to contextualize and compare
the nematode encountered data.
At 30 days of differentiation, patient iPSC-derived
DAn do not show overt morphological signs of neurode-
generation [20]. However, almost 40% of DAn positive
for the DA marker tyrosine hydroxylase (TH) showed
detectable amounts of α-SYN [20]. For this reason, and
to explore early events affecting PD, we next investigat-
ed the contribution of RAC1 in PD by rescuing α-SYN
accumulation in DAn. For this purpose, PD-iPSC-derived
midbrain DAn (at 30 days of differentiation when α-
SYN accumulation is already evident), were transduced
with lentivirus (LV) expressing either RAC1 wild type
(RAC1 (WT)-GFP or a highly active form of RAC1
(RAC1 (CA-GFP), and LV-GFP as control (Control-
GFP) (Online Resource 6a, c and d), and analyzed 7 days
after transduction. We found that LRRK2-PD-derived
DAn, transduced with Control-GFP showed significant
increase in α-SYN content in comparison with non-PD-
derived DAn (Fig. 6a, first and second panels, and scat-
ter dot plot) confirming previous results [20]. A 18%
decrease in α-SYN accumulation was observed in PD-
derived cells infected with RAC1 (WT)-GFP, and it was
even stronger (48.15%) in PD-derived cells infected with
RAC1 (CA)-GFP (Fig. 6a, third and fourth panels, and
scatter dot plot, ***P < 0.001). By analyzing the number
and length of neurites, to explore the capacity of Rac1 in
rescuing neuronal degeneration (Online Resource 7), we
found a decrease in neurite arborization in PD-derived
DAn (Fig. 6b), confirming previous reports showing re-
duction in neurite length/branching and defects of Rac
signaling in LRRK2-associated parkinsonism [53].
Importantly, overexpression of RAC1 (CA)-GFP, but
not RAC1 (WT)-GFP, was associated with significant
increase of neurite arborization (Fig. 6b, fourth panel
and left graph), consistent with a role for RAC1 in or-
ganizing the actin cytoskeleton [58]. The neurite length
was not rescued in any of the conditions tested (Fig. 6b,
right graph).
Fig. 5 Rac1 activity decreases α-SYN accumulation and
aggregation in the neuroblastoma cell l ine BE(2)-M17. a
Representative confocal images of α-SYN over-expressing cells
induced with 10 μM retinoic acid (RA) and treated with 10 mM
sodium butyrate (SB) for 36 h. Cells were transduced with Control-
GFP (upper row), RAC1 (WT)-GFP (middle row) and RAC1 (CA)-
GFP (bottom row), and co-stained for Thioflavin S (green) and α-
SYN (red). Arrows indicate Thioflavin S positive aggregates with
amyloidal structure. b Bar graph showing the quantitative analyses
of the neuronal soma area (in percentage %) covered by Thioflavin
S positive stain in individual cells transduced with (WT)- or (CA)
RAC1 or with the corresponding control. N = 14 (EV), N = 25 (WT),
and N = 24 (CA), from at least three independent experiments. Data
are presented as mean ± SEM. Statistics, ***P < 0.001, one-way
ANOVA with Bartlett’s test correction followed by post hoc Tukey
test. Scale bars represent 10 μm
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By transcriptome analysis we have previously reported that
iPSC-derived DAn from PD patients exhibited a large number
of gene expression changes. More specifically, we identified
437 differentially expressed genes (DEGs) in PD vs. controls
of which 254 were up-regulated in PD patients and 183 were
down-regulated [54]. Here, to gain further insight into the
canonical pathways affected by differential gene expression
detected at early PD, we performed a biological enrichment
analysis at 30 days of differentiation, by using the software
and databases of Ingenuity PathwayAnalysis (IPA).We found
that the signaling by Rho family GTPases pathway was the
top-1 statistically most significant canonical pathway in PD
pat ien t s compared to cont ro l s (P = 2.56 × 10−4 )
(Online Resource 8). From the total of 245 members com-
prised in this pathway, 16 DEGs of which 9 genes were up-
regulated and 7 down-regulated in PD DAn (Online Resource
9). Interestingly, the top 2 statistically most significant canon-
ical pathway was the related Rho GDI pathway (P = 7.91 ×
10−4). Overall, the results from this unbiased biological en-
richment analysis identifies Rho family GTPases as top
deregulated canonical pathway in iPSC-derived DAn from
PD patients.
Fig. 6 Rac1 activity rescues α-SYN accumulation and neurite
degeneration in early LRRK2-PD-derived DAcells. a First row shows
confocal images of non-PD (first panel) and LRRK2-PD-iPSC-derived
DAn (second, third, and fourth panels) at 30 days of differentiation
transduced with Control-GFP (first and second panels), RAC1 (WT)-
GFP (third panel) and RAC1 (CA)-GFP (fourth panel), and co-stained
for GFP (green), Tyrosine hydroxylase (TH) (red) and α-SYN (gray).
Nuclei are counterstained with DAPI, shown in blue. Second row
shows confocal images representing the expanded pictures of the
corresponding above neurons highlighted within the white dashed
square, evidencing α-SYN staining. Dot plot shows the quantification
of the average (in %) of α-SYN fluorescent intensity in every analyzed
neuron positive for TH and GFP. Statistical analysis is the result of
comparing α-SYN staining intensity of non-PD with LV-transduced
DAn. Data is the average of at least two-independent experiments and
are presented as mean ± SEM. Statistics is one-way ANOVA with a
Tukey’s post hoc analysis **P < 0.01. b Representative confocal
micrographs of single DAn derived from non-PD (first panel) and
LRRK-2PD patients, transfected with Control-GFP (second panel),
RAC1 (WT)-GFP (third panel) or RAC1 (CA)-GFP (fourth panel).
Extension bars are 10 μm. (Left graph) This bar graph represents the
number of neurites per neuron (primary, secondary and tertiary),
according to the indicated transduction, in non-PD and in PD-derived
cells. Statistical analysis is the result of comparing neurite number non-
PD with LRRK2-PD-derived DA cells transduced with RAC1 (WT)-
GFP or RAC1 (CA)-GFP. Data is the average of at least two-
independent experiments and are presented as mean ± SEM. Statistics is
One-way ANOVA, *P < 0.05 and **P < 0.01. (Right graph) Quantitative
analyses of the neurite length (in μm) in DAn derived from non-PD and
LRRK2-PD-derived patients. Statistical analysis is the result of
comparing neurite number non-PD with LRRK2-PD-derived DA cells
transduced with RAC1 (WT)-GFP or RAC1 (CA)-GFP. Data are
presented as mean ± SEM. Statistics is one-way ANOVA. ***P < 0.001
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RAC1 Activity Increases the Long-Term Survival
of PD-Patient-Derived DAn and Alleviates
the Impairment of Autophagy
To assess whether the protective effect of RAC1 in reducing
α-SYN levels correlated with increased survival rates over
t ime, neurons were further cultured for 75 days
(Online Resource 6b) by co-culturing them over a monolayer
of mouse post-natal cortical astrocytes [55], which supported
viable cultures of DAn for up to 75 days [20].
After this time span, differentiated cultures from genetic
LRRK2-PD- patient derived DAn showed higher numbers of
apoptotic DAn when compared to those derived from healthy
subjects [20] and Fig. 7(a, b, and e). Overexpression of both
RAC1 (CA)-GFP and RAC1 (WT)-GFP prevented cell death
by reducing the amount of DAn positively stained for cleaved
caspase-3 to the levels of the non-PD-patient-derived DA cells
(Fig. 7(c–d and e)). We and others have described that LRRK2
G2019S mutation has negative effects in the autophagic flux
by seemingly impairing autophagosome-lysosome fusion [20].
In this specific case, RAC1 CA (RAC1-(CA) but not RAC1
wild type (RAC1-(WT) displayed autophagosome vesicle
numbers similar to those of the non-PD-patient-derived neu-
rons (Fig. 7). Therefore, these results suggest a mechanism by
which a better performance of the autophagic clearance pro-
moted by RAC1 alleviates the accumulation of aggregation-
prone proteins, such as α-SYN, thus contributing to increase
the survival of DAn.
In conclusion, these results obtained in DAn derived from
LRRK2-associated PD patients are in line with findings in the
nematode models of PD, where RAC1 activity is directly in-
volved with DAn survival in the presence of α-SYN, α-SYN
inclusions formation and autophagic mechanisms.
Discussion
Here, we demonstrate in C elegans and in human-derived PD
cells that RAC1/ced-10 participates in the main pathogenic
manifestations of PD such as DAn death, α-SYN accumula-
tion and impaired autophagy. Besides, the results obtained in
the nematode, suggest a role of ced-10modulating DA behav-
ior in the presence of α-SYN. Furthermore, RAC1 function is
associated with the considered toxic α-SYN species. Overall,
in this manuscript we propose RAC1/ced-10 as a potential
therapeutic target for the treatment of PD-related disorders.
RAC1/ced-10 and DAn Death
Previous research has shown that Rac GTPases play an essential
neuroprotective and pro-survival role in neuronal models and
diseases [17, 56–58]. Indeed, our in depth analysis of the RAC1
signaling pathway arose from the transcriptomic data in human
iPSC-derived DAn from PD patients, showing altered Rho sig-
naling as top deregulated pathway, points to this same direction
(Online Resources 8–9). However, Rac GTPases modulation
in different cell types is much more complex. Loss of RAC
GTPase activity may contribute to the death of DAn while in-
creased Rac-GTP activity in microglia may contribute to the
formation of toxic ROS [59]. Hence, this complicated RAC1
modulation depending upon the tissue and the ROS state, might
explain the behavioral differences observed between whole ced-
10 mutant animals and RAC1/ced-10 specifically depleted in
DAn in the presence of α-SYN (Fig. 1). Interestingly, a cell
non-autonomous function for hypodermal RAC1/ced-10 in the
maintenance of axonal survival has been recently proposed in
C. elegans [60]. Consequently, the influence of RAC1 activity
in the neighboring tissues cannot be obviated.
There exist positive correlation between neuronal apoptosis
and decreased RAC1 GTPase activity [17]. Very different cel-
lular models, such as human lymphoma cells or primary cer-
ebellar granule neurons, suggest the inhibition of caspase-
induced apoptosis by RAC1, whereby AKT-dependent pro-
survival pathways and the consequent Bcl-2-associated death
protein (BAD) phosphorylation were downstream and activat-
ed by RAC1 [59, 61].
The activation of the AKT by RAC1, also participates in
the cytoskeleton reorganization and cellular growth [62, 63]
Fig. 7 RAC1 activity increases the long-term survival of PD-derived
DAn and alleviates autophagy impairment. (A–D) Confocal images of
non- PD (A) and PD-iPSC-derived DA cultures transduced with Control-
GFP (B), RAC1 (WT)-GFP (C), and RAC1 (CA)-GFP (D), stained for
GFP (green), TH (red) and cleaved Caspase-3 (white). A representative
area was highlighted in dashed lines and expanded in below panels. The
corresponding lower insets show higher magnification images of each
separate channel, cleaved caspase-3, TH and RAC1-GFP respectively.
TH+ neurons, stained with Caspase-3 and transduced with RAC1-GFP
constructs are labeled with white arrow tips. Caspase-3 posoNuclei are
counterstained with DAPI, shown in blue. PD-derived cells transduced
with Control-GFP (second panel) showed increased numbers of triple
positive TH/GFP/Caspase 3 staining in TH+ neurons in comparison to
the other conditions tested, where cells were non-PD (first panel left) or
transduced with RAC1 (WT)-GFP and RAC1 (CA)-GFP (third and
fourth panels respectively). Extension bar from A–D is 20 and 10 μm
for top and bottom panels respectively. e Bar graph showing the
quantification of the number of TH/GFP double-positive neurons
presenting cleaved Caspase-3 staining. Data is the average of at least
two-independent experiments and are presented as mean ± SEM.
Statistics, *P < 0.05, **P < 0.01, and ***P < 0.001, Two-way ANOVA,
Tukey post hoc test. f Confocal images of non-PD (left panel) and PD-
iPSC-derived DA cultures transduced with Control-GFP (second row),
RAC1 (WT)-GFP (third row), and RAC1 (CA)-GFP (fourth row), stained
for GFP (green), TH (red) and LC3 (gray). Non-PD cells (first row) and
PD cells transduced with RAC1 (CA)-GFP (fourth row) showed similar
amount of LC3-II positive vesicles in TH+/GFP+ neurons. Nuclei are
counterstained with DAPI, shown in blue. Extension bar is 5 μm. g Bar
graph showing the quantification of the neuronal soma area (in percentage
%) covered by LC3-II positive vesicles in at least 15 DA neurons. Data is
the average of at least two-independent experiments and are presented as
mean ± SEM. Statistics, *P < 0.05, Two-way ANOVA, post hoc Tukey
test
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and a failure to maintain the integrity of DAn after they are
formed could cause DAn death [64]. Accordingly, RAC1-
modulated processes involved in the maintenance of cell in-
tegrity, might be crucial for cell survival.
LRRK2-PD-patient-derived DAn show increased neurite
numbers after being transduced with RAC1 (Fig. 6), thus
expanding the role of this GTPase in the maintenance and in
the generation of new neurites [13], and thus contributing
accordingly to DAn survival (Fig. 7). Therefore, our results
are in accordance with LRRK2 inducing neurite retraction
through diminished RAC1 GTPase activity [16].
Surprisingly, neurite length was not rescued with any of the
infected RAC1 constructs in the present manuscript.
Differences between results can be explained based on the
different cellular models used in both laboratories, since our
results are provided directly from PD-derived cells, whereas
the neuroblastoma cell line SHSY5Y is the model used by
Chan et al. [16]. In addition, the existing actin-microtubule
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cross talk in the process of neurite outgrowth and elongation
has to be considered [65, 66]. Microtubules are the main cy-
toskeletal components of neurites [66] and decreased stability
of microtubules is a common feature of neurodegenerative
diseases [67]. Interestingly, LRRK2-PD variants are charac-
terized by defects in microtubule associated processes [68]
and LRRK2 regulates microtubule stability [69].However, ex-
tension and navigation of neurites are normally driven by
actin-rich growth cones and inhibition of microtubules dy-
namics does not stop neurite outgrowth [66]. Thus, our results
are consistent with cellular dysfunction in PD, with RAC1
modulating actin-associated mechanisms better than in micro-
tubule linked processes.
RAC1/ced-10 and α-SYN Accumulation
One of the main factors linked with DAn death in PD
progression is α-SYN accumulation. α-SYN overexpres-
sion in model systems, and its concomitant aggregation
and deposition precede neuronal cell death. In the case
of DAn, its degeneration is influenced by intracellular
and extracellular α-SYN accumulation, mainly in its olig-
omeric form [70]. Interestingly, extracellular oligomeric
α-SYN impairs RAC1 activity in neuroblastoma cells
[70]. Considering the increased intracellular α-SYN
aggregates together with increased oligomeric α-SYN
species observed in ced-10 mutant animals, we hypothe-
size that altered RAC1/ced-10 function might accelerate
α-SYN accumulation and the formation of α-SYN oligo-
mers which might bind concurrently RAC1/ced-10 [70]
thus increasing the severity of RAC1/ced-10 altered func-
tion. Moreover, and considering the modulation of the
actin cytoskeletal dynamics by α-SYN [71], a synergistic
regulation between RAC1 and α-SYN cannot be
excluded.
Additional experiments, where the amount of α-SYN
could be tightly controlled, will provide some clues about
the relevance of RAC1/α-SYN interaction in the progress of
PD.
α-SYN accumulation in PD patients is associated with fail-
ure of the two major protein breakdown pathways, the ubiq-
uitin proteasome system (UPS) and autophagy [72–74],
which, in cooperation, reduce the misfolded protein burden
[75]. Stably increased levels of α-SYN can lead to impaired
proteasome function [76] and ced-10 is proteasome regulated
in the phagocytosis of dead cells [14]. Hence, we hypothesize
that increased α-SYN in a ced-10 mutant background might
reinforce the severity of the ced-10 mutation in the degrada-
tion of α-SYN, due to the interaction of α-SYN with the
proteasomal machinery.
Fig. 7 (continued)
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Overexpression of α-SYN results in the inhibition of au-
tophagy [77]. Here we suggest RAC1/ced-10 being necessary
for autophagy to occur (Figs. 3 and 7). Accordingly, α-SYN
accumulation, due to ced-10 impairment, might increase the
severity of ced-10 mutation. Therefore we add RAC1 to the
already proposed feedback loop between proteasome activity
and autophagy [1] and we propose that a tight regulation of
RAC1 function is required to avoid excess of α-SYN accu-
mulation and the concomitant cell death.
Impaired autophagy associated with LRRK2 mutations are
already reported [78, 79], with the G2019S mutation showing
less autophagic activity [80]. In the context of LRRK-2 in-
duced phenotypes, we propose RAC1-LRRK2 interaction as
relevant factor favoring autophagy to occur, and helping in the
clearance of α-SYN aggregates, thus warranting the proper
neurite growth and maintenance.
Future scientific research is needed to unravel the mecha-
nisms associated with PD-related disorders for finding effi-
cient therapies. In light of our results the pharmacological
modulation of RAC1 and RAC1-derived signaling pathways




Nematodes were maintained using standard procedures [81].
We obtained the strains CB1112 cat-2(e1112), NL5901, unc-
119(ed3) III; [pkIs2386 (Punc-54::α-SYN::YFP; unc-119(+
))]; DA2123 adIs2122 [Plgg-1::lgg-1::GFP; rol-6(su1006)]
and HZ589, bpIs151 [Psqst-1::sqst-1::GFP; unc-76(+)] IV;
him-5(e1490) V from the Caenorhabditis elegans Genetic
Center (CGC). The strain BR3579, ced-10(n3246) was a gen-
erous gift from Dr. Ralf Baumeister (Albert-Ludwing
University, Freiburg/Breisgau, Germany).
The strain BR3579 was crossed with NL5901 animals to
generate the strain EDC101, unc-119(ed3) III; pkIs2386
[Punc-54::α-SYN::YFP; unc-119(+)]; ced-10(n3246).
The following strains is used to analyze the DAn degener-
ation as reported in Harrington et al., 2010 [36]: Pdat-1::α-
SYN +Pdat-1::GFP from the main text is named UA196,with
the genotype: sid-1(pk3321); baIn33 [Pdat-1::sid-1; Pmyo-
2::mCherry]; baIn11 [Pdat-1::α-SYN; Pdat-1::GFP].
For autophagy experiments, males from the DA2123 strain
[Plgg-1::lgg-1::GFP; rol-6(su1006)] were crossed with ced-
10(n3246) hermaphrodites. Males a from the HZ589
bpIs151 [Psqst-1::sqst-1::GFP; unc-76(+) IV]; him-5(e1490)
V] strain, expressing SQST-1::GFP crossed with ced-10
(n3246) hermaphrodites.
N2 (Bristol) was used as the C. elegans wild-type (wt)
strain. Hermaphrodites were used throughout of the
study.
RNAi Feeding
For feeding RNAi bacteria, egg lay from gravid adults were
directly transferred to NGM plates containing 1 mM of iso-
propyl β-D-1-thiogalactopyranoside/ IPTG (referred to as
RNAi plates) seeded with 20X concentrated bacteria contain-
ing 50μg/ml ampicillin, carrying desired plasmid for RNAi of
a specific gene (ced-10 or cat-1, depending upon the experi-
ment) or bacteria carrying empty (EV) pL4440 as control and
allowed to grow on plates for approximately 50 h to reach the
L4 stage and then another 16 h for the conduction of actual
experiment.
Note: Bacterial clones for RNAi feeding protocol were
obtained from the Ahringer library (Source Bioscience,
Nottingham, UK) [82] and were then streaked on LB-
Tetracycline-Ampicillin plate which was then incubated at
37 °C. Individual colonies from this freshly streaked plate
were grown for 10–12 h constantly shaking at 37 °C in LB
medium containing 50 μg/ml ampicillin.
Blinding of Experiments and Replicates
All behavioral studies were completed such that the ex-
perimenter was blind to the genotype of the worms.
Strains were given letter codes by another member of
the laboratory and the code was not broken until all of
the replicates for a particular assay were completed. For
all assays, we completed a minimum of three biological
replicates per strain.
Behavioral Experiments
Locomotor Rate Assay Locomotor rate assay was performed
as described in [33]. Briefly, assay plates were prepared by
spreading the E. coli strain OP50-1 in a ring on NGM agar
[81] in 5-cm petri plates. Assay plates were always freshly
spread with bacteria, incubated overnight at 37 °C, and
allowed to cool to room temperature before use. Plates for
measuring locomotor rate in the absence of bacteria were also
incubated at 37 °C. Only synchronized young adult hermaph-
rodites (16 h after the late L4 larval stage) were tested. For
well-fed animals, locomotor rate was measured by removing 5
animals from plates with ample bacteria, washing the animals
twice in S basal buffer [81], and transferring them to an assay
plate in a drop of buffer using a capillary pipette. The drop of
buffer used to transfer the animals was absorbed with a
Kimwipe. Five minutes after transfer, the number of body
bends in 20 s intervals was sequentially counted for each of
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the five animals on the assay plate and then repeated the same
thing for next set of animals in a different assay plate.
Ethanol Avoidance Assay Ethanol avoidance assay was per-
formed as described [34] (Cooper et al. 2015).
Synchronized young adult hermaphrodites (16 h after
the late L4 larval stage) were transferred to assay plates,
which are divided into four quadrants: two quadrants
seeded with 50 μl of 100% ethanol and the others with-
out. Worms are placed in the center of the assay plate
and allowed to move for 30 min at which point the entire
plate is imaged and the worms are scored for their quad-
rant of preference. Ethanol avoidance is calculated as
[(number of worms in control quadrants) − (number of
worms in ethanol quadrants)]/total number of worms.
Generation of the Rescue Construct Pced-10:: CFP::ced-10
Pced-10::CFP::ced-10 plasmids were co-injected into worm
strain EDC101 and UA196 to generate UA281, baEx167
[Pced-10 : :CFP: :ced-10 , ro l -6 ( su1006) ] ; [Punc-
54::α-SYN::YFP;ced-10(n3246)] and UA282, baEx167
[Pced-10::CFP::ced-10; rol-6(su1006)]; sid-1(pk3321);
baIn33 [Pdat-1::sid-1, Pmyo-2::mCherry]; baIn11[Pdat-
1::α-SYN; Pdat-1::GFP]). Hermaphrodites were used
throughout of the study.
Site-Directed Mutagenesis The construct Pced-10::GFP::ced-
10 was provided by Erik Lundquist (University of Kansas,
Lawrence, KS, USA) as a gift. TagMaster Site-directed muta-
genesis (GMBiosciences, Rockville, USA) was used to create
mutations (Y66W, Y145F, and M153T) in GFP sequence for
changing fluorescence marker as CFP. The product plasmid
Pced-10::CFP::ced-10 was sequenced (Eurofins Genomics,
Huntsville, AL, USA) to confirm the presence of the desired
mutations.
C. elegans Neurodegeneration Assays Worms were analyzed
for DA neurodegeneration as described previously [38].
Briefly, 10 L1-stage worms (neuron-specific RNAi worm
strain with α-Syn UA196 were transferred to the plates (emp-
ty vector (EV) and ced-10 RNAi) and grown at 20 °C until
adulthood. Adult worms were then transferred to correspond-
ing freshly made RNAi plates and allowed to lay eggs for 6 h
to synchronize. α-SYN-induced DA neurodegeneration was
scored at the indicated days after hatching (L4 + 7; L4 + 3;
L4 + 1). To investigate the effect of CED-10 overexpression
on α-SYN –induced DA degeneration, the strain UA282 was
analyzed at L4 + 7 days of aging. Worms were considered
normal when all six anterior DA neurons (four CEP
(cephalic) and two ADE (anterior deirid)) were present with-
out any visible signs of degeneration. If a worm displayed
degeneration in at least one of the six neurons, it was scored
as exhibiting degeneration. In total, at least 50 adult worms
were analyzed for each independent transgenic line or RNAi
treatment.
Aggregate Quantification The quantification of aggregates
was performed as previously described [83]. Briefly,
NL5901animals without and with ced-10(n3246) mutation,
together with the EDC101, were age-synchronized by
bleaching with NaOCl and left overnight to hatch. L1 animals
were transferred onto individual NGM plates seeded with
Escherichia coli. Aggregates were counted for each animal
staged at L4 + 5 days. Images were captured using a Leica
SP5 confocal microscope with a ×40 oil immersion lens
(HCX PL APO CS). The number of α-syn aggregates was
determined in the mid body of each animal, taking the vulva
position (V) as a reference. Aggregates were defined as dis-
crete, bright structures, with boundaries distinguishable from
surrounding fluorescence. Measurements on inclusions were
performed using ImageJ software taking into consideration
the area dimensions.
Thrashing Assays At L4 + 5 days, animals from the strains N2
wild type, NL5901 [unc-119(ed3) III; pkIs2386 [Punc-
54::α-SYN::YFP; unc-119(+)] and EDC01 unc-119(ed3) III;
pkIs2386 [Punc-54::α-SYN::YFP; unc-119(+)]; ced-10
(n3246) were placed in a drop of M9 buffer and allowed to
recover for 120 s (to avoid observing behavior associated with
stress) after which the number of body bends was counted for
1 min. Movies of swimming worms were recorded using a
Leica MZFFLIII stereomicroscope at nominal magnification
of 30X and the Hamamatsu ORCA-Flash 4.0LT camera at 17
frames per second (17 fps) for 1 min. Bends per minute were
obtained with theWorm Tracker pluggin (wrMTrck), from the
ImageJ software [84]. Thirty animals were counted in each
experiment unless stated otherwise. Experiments were carried
out in triplicate. Statistical analysis was performed using
Graphpad Prism version 6.00 for Windows, GraphPad
Software, La Jolla, CA, USA).
Detergent Fractionation α-SYN oligomeric species were iso-
lated by detergent fractionation as described (Kuwahara et al.
2012) with slight modifications. Briefly, worms were washed
three times with M9 buffer, collected as a 100 μl pellet, and
the pellet was snap-frozen in liquid nitrogen. The pellets were
homogenized in 1 mL of 50 mM Tris-HCl buffer at pH 7.5
with complete protease inhibitor mixture (Roche Applied
Science) by brief sonication. Sonicates were centrifuged two
times at 1000×g for 5 min to remove debris of worm tissue.
The supernatant was then ultracentrifuged at 350,000×g for
15 min, and the supernatant was collected as a Tris-HCl sol-
uble fraction. The resulting pellet was subsequently extracted
by sonication in 500 μl of Triton X-100 (Tris-HCl buffer with
1% TritonX-100), 200 μl of Sarkosyl (Tris-HCl with 1%
Sarkosyl), and 100 μl of SDS (TrisHCl with SDS sample
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buffer containing 2% SDS) followed by centrifugation at
350,000×g for 15 min. The Tris-HCl fraction containing
20 μg of total proteins, along with equal volumes of Triton
X-100, Sarkosyl, and SDS fractions to the Tris-HCl fraction,
were loaded onto the acrylamide gel and separated by SDS-
PAGE.
Immunoblotting Twenty microliters of protein per strain were
loaded from each sample and fraction on Novex NuPAGE 4–
12%Bis-Tris Gels (Thermo Fisher) an run inMES SDS buffer
at 200 V for 40 min. Resolved proteins were transferred onto
0.45 μm nitrocellulose membranes (Amersham) at 200 mA
for 1 h. Blocking was done in 5%milk powder in PBS for 1 h,
followed by overnight incubation at 4 °C with a mouse mono-
clonal antibody againstα-synuclein (1:1000, BDBiosciences,
#610787) diluted in 2% bovine serum albumin (BSA)/PBS.
Incubation with a donkey anti-mouse (1:5000, Amersham)
secondary antibody diluted in 1% milk powder/PBS was per-
formed for 1 h at room temperature.
Membranes were developed using SupersignalWest Femto
(Thermo Scientific) in a ImageQuant RT ECL Imager (GE
Healthcare).
Autophagy Measurements For measuring the involvement of
ced-10(n3246) mutation in autophagy, we followed specific
C. elegans protocols [48, 85]. LGG-1::GFP foci were ana-
lyzed in the hypodermal seam cells at L3 stage of develop-
ment. Images were not considered for quantification where the
hypodermis was not clear. In total, at least 40 total regions
were quantified from 30 different worm samples per
genotype.
To confirm the involvement of ced-10 in impairing autoph-
agy, we followed the protocol described in [86]. Pictures of L1
animals (whole animal) and L4 animals (whole intestine),
were analyzed by using a 63× objective. The GFP internal
intensity (FI), corresponding to SQST-GFP foci, was quanti-
fied at L4 stage of development. The presence of the ced-10
mutation was checked by PCR as described [14]. The pres-
ence of the GFP reporter was double checked by PCR using
the gfp primers, and under the fluorescence microscope.
Microscopy and Imaging For neurodegeneration assays and
aggregates quantification animals were mounted with a cov-
erslip on a 4% agarose pad in M9, containing 10 mM of
sodium azide. Confocal microscopy was performed using a
Leica TCS-SP5 confocal spectral microscope (Leica,
Barcelona, Spain) and analyzed using ImageJ software
(NIH, ver. 1.43, Schindelin, 2015). Animals were examined
at 100× magnification to examine α-SYN induced DA cell
death and at 40X to examine α-SYN apparent aggregates.
For autophagy measurements, animals were placed in a
5 μL drop of 10 mM solution of levamisole (Sigma-Aldrich,
Madrid, Spain). For each independent experiment, between
20 and 30 7-day-old worms of each treatment were examined
under a Nikon EclipseTE2000-E epifluorescence microscope
equipped with a monochrome camera (Hamamatsu ORCA-
ER) coupled to the Metamorph software (Molecular Devices
Corp., Sunnyvale, CA). The system acquires a series of frames
at specific Z-axis position (focal plane) using a Z-axis motor
device.
Cell Culture Experiments in BE(2)-M17 Neuroblastoma
Cell Line
Cell Culture
Human neuroblastoma cell line BE(2)-M17 over-expressing
wild type α-SYN were maintained at 37 °C and 5% CO2 in
Optimem medium (Gibco) (Thermo-Fisher Scientific,
Madrid, Spain) supplemented with 10% fetal bovine serum
(Gibco) (Thermo-Fisher Scientific, Madrid, Spain),
500 μg/ml G418 (Geneticin) (Sigma-Aldrich, Madrid,
Spain) and Penicillin/Streptomycin (Sigma-Aldrich, Madrid,
Spain). For immunofluorescence, 2 × 104 cells/well were
seeded in 24-well plates on coverslips coated with poly-D-
lysine. α-SYN aggregation was induced as previously report-
ed ([51] by differentiation with 10 μM retinoic acid (Sigma-
Aldrich, Madrid, Spain) for 10 days, followed by treatment
with the histone deacetylases inhibitor sodium butyrate (SB)
(Sigma-Aldrich, Madrid, Spain) at a concentration of 10 mM
for 36 h. To analyze the effect of RAC1 on α-SYN aggrega-
tion, cells were transduced 24 h before SB treatment with
either the lentiviral empty vector or with the wild type or the
constitutively active isoforms of RAC1 at an estimated multi-
plicity of infection (MOI) of 5.
Immunofluorescence
BE(2)-M17 cells were fixed in 4% paraformaldehyde (PFA)
(Sigma-Aldrich, Madrid, Spain) in phosphate saline buffer
(PBS) for 30 min at 4 °C and permeabilized with Tris-
buffered saline (TBS) containing 0.5% Triton X-100
(Sigma-Aldrich, Madrid, Spain) for 5 min. Cells were then
blocked with 3% normal goat serum (NGS) (Vector
Laboratories, Palex Medical, Sant Cugat del Vallès, Spain)
in TBS for 1 h and subsequently incubated with the corre-
sponding primary antibody in 1%NGS/TBS overnight at
4 °C. The following primary antibodies were used: mouse
anti-α-SYN (610,787; 1:500) (BD Biosciences, Madrid,
Spain), rabbit anti-α-SYN (2642; 1:500) (Cell Signaling,
Leiden, The Netherlands). Incubation with goat secondary
antibodies conjugated with Alexa488 (anti-mouse, A11001;
or Alexa594 (anti-mouse, A11005; anti-rabbit, A11012)
(Thermo-Fisher Scientific, Madrid, Spain) was done in 1%
NGS/TBS for 1 h at RT. Between each incubation period cells
were rinsed three times in TBS.
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Thioflavin S Staining
After incubation with the antibodies, coverslips were im-
mersed in 0.005% thioflavin S (Sigma-Aldrich, Madrid,
Spain) in PBS for 8 min and then rinsed twice in ethanol
70% and once in PBS. Only after thioflavin S staining, nuclei
were counterstained with Hoechst 33342 (Thermo Fisher
Scientific, Madrid, Spain, 1:10,000 in PBS) for 10 min.
Microscopy and IF Quantification
Cells were cover slipped using Dako Cytomation Fluorescent
Mounting Medium (Dako, Sant Just Desvern, Spain).
Immunofluorescence images were acquired using standard
filter sets using an Olympus FluoView TM FV1000 confocal
microscope and the FV10_ASW 4.2 visualization software.
α-SYN fluorescence intensity for each condition was ana-
lyzed in an average of 150 cells from 6 different random fields
at an objective magnification of 40×. Quantification of
Thioflavin S positive aggregates in each condition was ana-
lyzed in an average of 20 cells from 3 different random fields
by measuring the fluorescent area per cell. All quantification
analyses were done using ImageJ software (NIH, USA).
Cell Culture Experiments with iPSC Cell Lines Derived
from Human Patients
Previously generated iPSC lines SP-11.1 (from control) and
SP-12.3 (from patients with familial PD with the LRRK2
G2019S mutation) were used and culture and differentiation
were carried out as described, (34), following a protocol ap-
proved by the Spanish competent authorities (Commission on
Guarantees concerning the Donation and Use of Human
Tissues and Cells of the Carlos III Health Institute). Briefly,
hiPSC were cultured on matrigel (Corning Limited, Life
Sciences, UK) and maintained in hESC medium, consisting
on KO-DMEM (Invitrogen, Thermo Fisher Scientific,
Madrid, Spain) supplemented with 20% KO-Serum
Replacement (Invitrogen, Thermo Fisher Scientific, Madrid,
Spain), 2 mM Glutamax (Invitrogen, Thermo Fisher
Scientific, Madrid, Spain), 50 μM 2-mercaptoethanol
(Invitrogen, Thermo Fisher Scientific, Madrid, Spain), non-
essential aminoacids (Cambrex, Nottingham, UK) and
10 ng/ml bFGF (Peprotech, London, UK). Medium was
preconditioned overnight by irradiated mouse embryonic fi-
broblast and hiPSC were maintained on Matrigel (Corning
Limited, Life Sciences, UK) at 37 °C, 5% CO2.
For DAn differentiation, iPSC were transduced with
LV.NES.LMX1A.GFP and processed as previously described
(79). Briefly, confluent iPSC 10 cm dishes were disaggregated
with accutase and embryoid bodies (EB) were generated using
forced aggregation method in V-shaped 96 well plates. Two
days later, EBs were patterned as ventral midbrain by
culturing them in suspension for 10 days in N2B27 supple-
mented with 100 ng/ml SHH (Peprotech, London, UK),
100 ng/ml FGF8 (Peprotech, London, UK) and 10 ng/ml
FGF2 (Peprotech, London, UK). Then, forα-SYN and neurite
analysis, differentiation to midbrain DAn was performed on
the top of PA6 murine stromal cells for 3 weeks (79). To
analyze α-SYN levels, neuronal cultures were gently
trypsinized and re-plated in matrigel-coated slides for 3 days,
then transduced with the two different RAC1 isoforms or the
control LV, at an estimated MOI of 10. Cells were fixed and
analyzed 7 days after transduction. For long-term culture stud-
ies, EBs were mechanically dissociated by repeated pipetting
after the induction step. Salient EB fragments were transduced
with the two different RAC1 isoforms or the control LVat an
estimated MOI of 3. Three days post-transduction, the aggre-
gates were seeded on primary murine astrocytes and cultured
for 9 weeks.
Lentiviral Vectors
RAC1 wild type (WT) and constitutively active (V12) (CA)
forms were amplified by means of PCR from expression plas-
mids kindly provided by (Dr Francisco Sánchez-Madrid;
Spanish National Center for Cardiovascular Research
(CNIC), Madrid, Spain). Subsequently, RAC1-(WT) and
RAC1-(CA) cDNA were cloned under the human phospho-
glycerate kinase (PGK) promoter of pCCL.cPPT-hPGK-
IRES.eGFP-WPRE lentiviral transfer vector. High-titer vesic-
ular stomatitis virus (VSV)–pseudotyped LV stocks were pro-
duced in 293T cells by calcium phosphate–mediated transient
transfection of the transfer vector, the late generation packag-
ing construct pMDL, and the VSVenvelope–expressing con-
struct pMD2.G, and purified by ultracentrifugation as previ-
ously described [87]. Expression titers, determined on HeLa
cells by fluorescence-activated cell sorter (FACS) analysis
(FACSCalibur, Becton Dickinson), were as follows: LV-
RAC1 (WT): 2.60 · 10^8 TU/mL; LV-RAC1 (CA): 2.24 ·
10^8 TU/mL; LV-PGK-GFP: 5.08 · 10^9 TU/mL.
Immunofluorescence for iPSC-Derived Cells
iPSC-derived cells were fixed with 4% paraformaldehyde
(PFA) in Tris-buffered saline (TBS) buffer for 20 min and
blocked in 0.3% Triton X-100 (Sigma-Aldrich, Madrid,
Spain) with 3% donkey serum for 2 h. In the case of α-SYN
and LC3 staining, Triton X-100 was kept at 0.01% for the
blocking and antibody incubation steps. The following prima-
ry antibodies were used: mouse anti-α-SYN (610787; 1:500)
(BD Biosciences, Madrid, Spain), rabbit anti-TH (sc-14007;
1:500) (Santa Cruz Biotechnology, Madrid, Spain), chicken
anti-GFP (1020; 1:250) from Aves Labs (Cosmo Bio, AbBcn
S.L., Bellaterra, Spain), rabbit anti-cleaved Caspase3 (9664;
1:400) (Cell Signaling) and LC3B (2775; 1:100) (Cell
7548 Mol Neurobiol (2018) 55:7533–7552
Signaling). Images were acquired using a Leica SP5 confocal
microscope.
α-SYN and Neurite Analysis
α-SYN and neurite analysis were performed after a total of
4 weeks of differentiation plus 1 week after LV transduction
on iPSC-derived DA neurons. DA neurons were randomly
selected, using a Leica SP5 confocal microscope, and ana-
lyzed with ImageJ for α-SYN intensity levels and with the
ImageJ plugin NeuronJ to determine the number of neurites
per cell, number of terminals and branch points.
Cleaved Caspase-3, Apoptotic Cell Number
and Autophagosome Accumulation and Analysis
Cleaved caspase-3, apoptotic cell number and autophagosome
accumulation analysis were performed after a total of 9 weeks
of differentiation on iPSC-derived DAn grown on murine as-
trocytes. DA neurons were randomly selected, using a Leica
SP5 confocal microscope, and analyzed with ImageJ to deter-
mine the fraction of the neuronal soma area stained by cleaved
caspase-3 or covered by LC3-positive particles.
Statistical Analysis
All experiments were performed at least three independent
times. All data are presented as mean ± SEM. Group means
were compared with either the Student’s t test or ANOVA. All
P values were two tailed, and a P value of less than 0.05 was
considered statistically significant. All statistical analyses
were analyzed using GraphPad Prism (San Diego, CA,
USA) software.
Outlier values were identified with the Grubbs’ tests and
excluded from the analysis.
Differences among means were analyzed either by 1- or 2-
way analysis of variance (ANOVA), as appropriate, using the
post hoc Tukey’s multiple comparison test. In all cases, the
null hypothesis was rejected at the 0.05 level.
Biological Enrichment Analysis
Transcriptomic analysis of iPSC-derived DAn from PD pa-
tients (n = 10) and healthy controls (n = 4) was done as previ-
ously described [54]. Identified differentially expressed genes
(DEGs) after multiple testing adjustment of P values (n = 437)
were subjected to biological enrichment analysis. To this end,
we used the Core Analysis module of the Ingenuity® Pathway
Analysis (IPA) software (Qiagen, Redwood City, www.
qiagen.com/ingenuity) to identify biological enrichment of
canonical pathways deregulated in iPSC-derived DAn from
PD patients. More specifically, we used the Ingenuity
Knowledge Base of Genes, and considered only direct
molecules and/or relationships for humans. Statistical signifi-
cance of canonical pathways was computed by using the
Fischer’s exact test and significance levels were set at P below
0.05. Using IPAwe also calculated Z-score values which con-
sider the directional effect of one molecule on another mole-
cule or on a process, and also the direction of change of mol-
ecules in the dataset and provide predictions about whether the
pathway is predicted to be activated or inhibited, or if the
pathway is ineligible for such an assessment.
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